On-Demand Webinar: How to Get Great Place To Work-Certified™
MENU
Tarsus

Tarsus

Updated April 2022.

98%

Employees say this is a great place to work


Company Overview

About The Company

Tarsus Pharmaceuticals applies proven science and new technology to revolutionize treatment for patients, starting with eye care. It is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology, and infectious disease prevention. The company is studying several investigational medicines in clinical trials. Its lead product candidate, TP-03, is a novel therapeutic being studied in a second pivotal trial for the treatment of Demodex blepharitis. In addition, Tarsus is developing TP-05, an oral, non-vaccine therapeutic for the prevention of Lyme disease, currently studied in a Phase 1b clinical trial.

COMPANY SIZE

50 U.S.-based Employees
(Small)

INDUSTRY

Biotechnology & Pharmaceuticals


Employee Demographics

Tenure

Company Culture at Tarsus

The employee experience below at Tarsus, compared to a typical company.

Learn More

98% of employees at Tarsus say it is a great place to work compared to 57% of employees at a typical U.S.-based company.

  • Tarsus
  • 98%
  • Typical Company
  • 57%
100%
Management is competent at running the business.
100%
People here are given a lot of responsibility.
100%
Management has a clear view of where the organization is going and how to get there.
100%
Management is honest and ethical in its business practices.
100%
I am given the resources and equipment to do my job.

Why Work at Tarsus?

See what employees say about what makes Tarsus a great workplace. These words are drawn from employee comments on the Trust Index™ survey.


Best Workplaces Lists

Great Place To Work® is proud to recognize Tarsus

Don't See Your Company Listed?

Nominate your company today to join Certification Nation

NOMINATE YOUR COMPANY